These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1423976)

  • 1. Conjunctive heparin therapy. Limitations of subcutaneous administration.
    Goldhaber SZ
    Circulation; 1992 Nov; 86(5):1639-41. PubMed ID: 1423976
    [No Abstract]   [Full Text] [Related]  

  • 2. Subcutaneous heparin during coronary thrombolysis. Too little, too late.
    Delanty N; Fitzgerald DJ
    Circulation; 1992 Nov; 86(5):1636-8. PubMed ID: 1423975
    [No Abstract]   [Full Text] [Related]  

  • 3. Principles and practice of coronary thrombolysis and conjunctive treatment.
    Sobel BE; Hirsh J
    Am J Cardiol; 1991 Aug; 68(4):382-8. PubMed ID: 1858680
    [No Abstract]   [Full Text] [Related]  

  • 4. Highly variable anticoagulant response after subcutaneous administration of high-dose (12,500 IU) heparin in patients with myocardial infarction and healthy volunteers.
    Kroon C; ten Hove WR; de Boer A; Kroon JM; van der Pol JM; Harthoorn-Lasthuizen EJ; Schoemaker HC; van der Meer FJ; Cohen AF
    Circulation; 1992 Nov; 86(5):1370-5. PubMed ID: 1423948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical examination of heparin-Ca in myocardial infarction patients.
    Páder K; Kerkovits G
    Ther Hung; 1990; 38(3):114-6. PubMed ID: 2284620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin modifies platelet count and function in patients who have undergone thrombolytic therapy for acute myocardial infarction.
    Balduini CL; Noris P; Bertolino G; Previtali M
    Thromb Haemost; 1993 May; 69(5):522-3. PubMed ID: 8322276
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarction.
    Wang XK; Zhang Y; Yang CM; Wang Y; Liu GY
    Clin Drug Investig; 2006; 26(6):341-9. PubMed ID: 17163268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are both aspirin and heparin justified as adjuncts to thrombolytic therapy for acute myocardial infarction?
    Ridker PM; Hebert PR; Fuster V; Hennekens CH
    Lancet; 1993 Jun; 341(8860):1574-7. PubMed ID: 8099650
    [No Abstract]   [Full Text] [Related]  

  • 9. Subcutaneous enoxaparin following thrombolysis and intravenous unfractionated heparin in ST-elevation acute myocardial infarction: safety and efficacy of low vs full dose.
    Rubboli A; Gatti C; Spinolo L; Parollo R; Spitali G; Maresta A
    Minerva Cardioangiol; 2006 Feb; 54(1):131-7. PubMed ID: 16467747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
    GUSTO investigators
    N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin as an adjunctive treatment after thrombolytic therapy for acute myocardial infarction.
    Prins MH; Hirsh J
    Am J Cardiol; 1991 Jan; 67(3):3A-11A. PubMed ID: 1990783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma free-fatty-acids and small doses of subcutaneous heparin in acute myocardial infarction.
    Arnesen H; Bjerkedal I; Skjaeggestad O; Godal HC
    Thromb Res; 1979; 14(4-5):541-9. PubMed ID: 483254
    [No Abstract]   [Full Text] [Related]  

  • 14. Heparin as an adjuvant to thrombolytic therapy in acute myocardial infarction.
    Metz BK; Topol EJ
    Biomed Pharmacother; 1996; 50(6-7):243-53. PubMed ID: 8952863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anticoagulant therapy in myocardial infarct. Considerations based on data from the literature and personal results obtained by the administration of subcutaneous heparin-calcium].
    Bernardi P; Cavazza M; Bastagli L; Fontana F; Ventura C; Spagnolo N; Guardigli G
    Clin Ter; 1986 Oct; 119(2):91-109. PubMed ID: 3791904
    [No Abstract]   [Full Text] [Related]  

  • 16. Low-dose heparin after myocardial infarction.
    Handley AJ
    Lancet; 1972 Sep; 2(7778):623-4. PubMed ID: 4116776
    [No Abstract]   [Full Text] [Related]  

  • 17. Cut down on hospital stays, heparin use: treating AMI in the thrombolytic era.
    Phillips L
    Hosp Technol Ser; 1996 Apr; 15(5):6. PubMed ID: 10158287
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Menon V; Harrington RA; Hochman JS; Cannon CP; Goodman SD; Wilcox RG; Schünemann HJ; Ohman EM
    Chest; 2004 Sep; 126(3 Suppl):549S-575S. PubMed ID: 15383484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The challenge of maintaining coronary arterial patency with intravenous heparin following tissue plasminogen activator administration.
    Becker RC; Gore JM
    Cardiology; 1993; 83(1-2):100-6. PubMed ID: 8261475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heparin].
    Aiach M; Fiessinger JN; Chousterman M
    Rev Prat; 1977 Dec; 27(57):3953-74. PubMed ID: 345399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.